Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/16647

TDMS Study 61938-01 Pathology Tables

NTP Experiment-Test: 61938-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 90-DAY                                   1-NITROPYRENE                                       Date: 10/18/04
Route: RESPIRATORY EXPOSURE NASAL                                                                                 Time: 08:33:57




       Facility:  Battelle Northwest

       Chemical CAS #:  5522-43-0

       Lock Date:  06/05/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All




































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 61938-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                   1-NITROPYRENE                                       Date: 10/18/04    
Route: RESPIRATORY EXPOSURE NASAL                                                                                 Time: 08:33:57    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   CONTROL      0.5          2.0          8.0          20.0         50.0            
                                                                MG/M3        MG/M3        MG/M3        MG/M3        MG/M3           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          12           12           12           12           12           12           
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
    Terminal Sacrifice                                10           10           10           10           10           10           
  Special Study                                        2            2            2            2            2            2           
                                                                                                                                    
  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (10)         (3)          (1)          (4)          (1)          (10)         
      Hepatodiaphragmatic Nodule                                    2 (67%)      1 (100%)     4 (100%)     1 (100%)     1 (10%)     
      Inflammation, Chronic                                         1 (33%)                                                         
      Inflammation, Chronic Active                                                                                      1 (10%)     
      Necrosis                                                                                                          1 (10%)     
      Necrosis, Focal                                  1 (10%)      1 (33%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (10)                                                             (10)         
      Cardiomyopathy                                   4 (40%)                                                          4 (40%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (10)                                   (1)                       (10)         
      Cyst                                             1 (10%)                                1 (100%)                  1 (10%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 61938-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                   1-NITROPYRENE                                       Date: 10/18/04    
Route: RESPIRATORY EXPOSURE NASAL                                                                                 Time: 08:33:57    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   CONTROL      0.5          2.0          8.0          20.0         50.0            
                                                                MG/M3        MG/M3        MG/M3        MG/M3        MG/M3           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node, Mediastinal                            (9)          (1)                                                 (10)         
      Hemorrhage                                                    1 (100%)                                                        
   Spleen                                             (10)                      (1)                                    (10)         
      Fibrosis                                                                   1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (10)                                                             (10)         
      Inflammation, Chronic Active                     1 (10%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Epiglottis, Metaplasia, Squamous                              4 (40%)      4 (40%)     10 (100%)    10 (100%)    10 (100%)    
   Lung                                               (10)         (10)         (10)         (10)         (10)         (10)         
      Hemorrhage                                      10 (100%)     8 (80%)      6 (60%)      9 (90%)      7 (70%)      9 (90%)     
      Inflammation, Chronic Active                                  5 (50%)      2 (20%)                   2 (20%)      2 (20%)     
      Alveolar Epithelium, Hyperplasia                 1 (10%)                                                                      
      Bronchus, Metaplasia, Squamous                                                                       2 (20%)      3 (30%)     
   Nose                                               (10)         (10)         (10)         (10)         (10)         (10)         
      Olfactory Epithelium, Cytoplasmic Alteration    10 (100%)    10 (100%)    10 (100%)    10 (100%)    10 (100%)    10 (100%)    
      Respiratory Epithelium, Cytoplasmic                                                                                           
        Alteration                                                                            6 (60%)     10 (100%)    10 (100%)    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 61938-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                   1-NITROPYRENE                                       Date: 10/18/04    
Route: RESPIRATORY EXPOSURE NASAL                                                                                 Time: 08:33:57    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   CONTROL      0.5          2.0          8.0          20.0         50.0            
                                                                MG/M3        MG/M3        MG/M3        MG/M3        MG/M3           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (10)                                                             (10)         
      Nephropathy                                      1 (10%)                                                          1 (10%)     
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 61938-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                   1-NITROPYRENE                                       Date: 10/18/04    
Route: RESPIRATORY EXPOSURE NASAL                                                                                 Time: 08:33:57    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     CONTROL      0.5          2.0          8.0          20.0         50.0            
                                                                MG/M3        MG/M3        MG/M3        MG/M3        MG/M3           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          12           12           12           12           12           12           
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
    Terminal Sacrifice                                10           10           10           10           10           10           
  Special Study                                        2            2            2            2            2            2           
                                                                                                                                    
  Animals Examined Microscopically                    10           10           10           10           10           10           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (10)         (2)          (4)          (1)          (1)          (10)         
      Hepatodiaphragmatic Nodule                       2 (20%)      2 (100%)     4 (100%)     1 (100%)     1 (100%)     1 (10%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (10)                                                             (10)         
      Cardiomyopathy                                   6 (60%)                                                          4 (40%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (9)          (10)         (10)         (9)          (10)         (10)         
      Hypospermia                                      9 (100%)    10 (100%)    10 (100%)     9 (100%)    10 (100%)    10 (100%)    
   Testes                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Atrophy                                         10 (100%)    10 (100%)    10 (100%)    10 (100%)    10 (100%)    10 (100%)    
      Mineralization                                   1 (10%)                                             2 (20%)      1 (10%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 61938-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                   1-NITROPYRENE                                       Date: 10/18/04    
Route: RESPIRATORY EXPOSURE NASAL                                                                                 Time: 08:33:57    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     CONTROL      0.5          2.0          8.0          20.0         50.0            
                                                                MG/M3        MG/M3        MG/M3        MG/M3        MG/M3           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Lymph Node                                         (1)                       (1)                       (1)                       
      Renal, Hemorrhage                                1 (100%)                  1 (100%)                  1 (100%)                 
   Lymph Node, Mediastinal                            (10)                      (1)                                    (8)          
      Hemorrhage                                                                 1 (100%)                                           
   Thymus                                             (10)                      (1)                                    (10)         
      Hemorrhage                                                                 1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (10)         (10)         (10)         (10)         (10)         (10)         
      Epiglottis, Metaplasia, Squamous                                           5 (50%)     10 (100%)    10 (100%)    10 (100%)    
   Lung                                               (10)         (8)          (10)         (10)         (10)         (10)         
      Hemorrhage                                      10 (100%)     8 (100%)    10 (100%)     9 (90%)     10 (100%)    10 (100%)    
      Inflammation, Chronic Active                                  3 (38%)      1 (10%)      2 (20%)      1 (10%)                  
      Bronchus, Metaplasia, Squamous                                                          1 (10%)      2 (20%)      5 (50%)     
   Nose                                               (10)         (10)         (10)         (10)         (10)         (10)         
      Olfactory Epithelium, Cytoplasmic Alteration    10 (100%)    10 (100%)    10 (100%)    10 (100%)    10 (100%)    10 (100%)    
      Respiratory Epithelium, Cytoplasmic                                                                                           
        Alteration                                                                            8 (80%)     10 (100%)    10 (100%)    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 61938-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 90-DAY                                   1-NITROPYRENE                                       Date: 10/18/04    
Route: RESPIRATORY EXPOSURE NASAL                                                                                 Time: 08:33:57    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     CONTROL      0.5          2.0          8.0          20.0         50.0            
                                                                MG/M3        MG/M3        MG/M3        MG/M3        MG/M3           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (10)                                                             (10)         
      Nephropathy                                      5 (50%)                                                          5 (50%)     
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------